
Solid Biosciences Inc
NASDAQ:SLDB

Fundamental Analysis


Revenue & Expenses Breakdown
Solid Biosciences Inc
Balance Sheet Decomposition
Solid Biosciences Inc
Current Assets | 313.4m |
Cash & Short-Term Investments | 306.9m |
Other Current Assets | 6.5m |
Non-Current Assets | 30.5m |
PP&E | 28.2m |
Other Non-Current Assets | 2.3m |
Free Cash Flow Analysis
Solid Biosciences Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Solid Biosciences Inc
Revenue
|
0
USD
|
Operating Expenses
|
-142.9m
USD
|
Operating Income
|
-142.9m
USD
|
Other Expenses
|
3.2m
USD
|
Net Income
|
-139.7m
USD
|
SLDB Profitability Score
Profitability Due Diligence
Solid Biosciences Inc's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

Score
Solid Biosciences Inc's profitability score is 20/100. The higher the profitability score, the more profitable the company is.
SLDB Solvency Score
Solvency Due Diligence
Solid Biosciences Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Score
Solid Biosciences Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SLDB Price Targets Summary
Solid Biosciences Inc
According to Wall Street analysts, the average 1-year price target for
SLDB
is 17.68 USD
with a low forecast of 15.15 USD and a high forecast of 21 USD.
Dividends
Current shareholder yield for SLDB is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?